Crispr Therapeutics Ag (CRSP) SEC Filings — 2024
16 SEC filings for Crispr Therapeutics Ag (CRSP) in 2024.
Filings
- Crispr Therapeutics Ag SC 13G/A Filing — SC 13G/A · Dec 10, 2024
- CRISPR Therapeutics Q3 2024 Update — 10-Q · Nov 5, 2024
- CRISPR Therapeutics AG Files Q2 2024 10-Q — 10-Q · Aug 5, 2024
- CRISPR Therapeutics AG Files 8-K on Corporate Governance and Officer Changes — 8-K · Jun 3, 2024
- CRISPR Therapeutics Files 8-K on Executive and Board Changes — 8-K · May 23, 2024
- CRISPR Therapeutics AG Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Crispr Therapeutics Ag SC 13G/A Filing — SC 13G/A · Apr 10, 2024
- CRISPR Therapeutics Files Proxy Materials — DEFA14A · Apr 9, 2024
- CRISPR Therapeutics AG Files 2023 Annual Report on Form 10-K — 10-K · Feb 21, 2024
- CRISPR Therapeutics Files 8-K for Undisclosed "Other Events" — 8-K · Feb 13, 2024
- Nikko Asset Management Exits CRISPR Therapeutics Stake — SC 13G/A · Feb 12, 2024
- Capital International Investors Trims CRISPR Therapeutics Stake to 7.6% — SC 13G/A · Feb 9, 2024
- Sumitomo Mitsui Trust Amends CRISPR Therapeutics Stake — SC 13G/A · Feb 5, 2024
- ARK Investment Management Holds 9.9% Stake in CRISPR Therapeutics — SC 13G/A · Jan 29, 2024
- CRISPR Therapeutics Files 8-K for 'Other Event' on Jan 16, 2024 — 8-K · Jan 16, 2024
- ARK Investment Management Discloses 9.9% Stake in CRISPR Therapeutics — SC 13G/A · Jan 10, 2024